INmune Bio, Inc.
(NASDAQ : INMB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.46%574.002.7%$671.54m
ILMNIllumina, Inc. -0.53%318.733.5%$654.95m
AMGNAmgen, Inc. -0.58%229.751.3%$595.71m
ARRYArray BioPharma Inc. 1.92%39.2414.2%$511.82m
GILDGilead Sciences, Inc. -0.33%60.351.0%$505.34m
MRNAModerna, Inc. -2.18%69.760.0%$492.74m
VRTXVertex Pharmaceuticals, Inc. -1.00%212.401.9%$474.86m
IMMUImmunomedics, Inc. 0.11%87.8211.0%$388.21m
NVAXNovavax, Inc. -5.45%93.0096.5%$308.29m
ALXNAlexion Pharmaceuticals, Inc. -3.30%119.912.0%$287.90m
BIIBBiogen, Inc. 1.09%270.031.6%$260.41m
EXASEXACT Sciences Corp. -2.45%100.5020.7%$223.72m
BNTXBioNTech SE -7.63%87.150.0%$208.24m
SRNESorrento Therapeutics, Inc. -1.47%8.101.4%$189.77m
SGENSeagen Inc. 1.52%201.026.0%$172.66m

Company Profile

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.